Free Research Report Download:
The Cancer Market Outlook To 2014
Free Pharmaceutical Market Research Reports
Biotechnology
Corporate & Fiscal
Drug Delivery
Health Products
Hospital Markets
Indication Areas
Medical Devices
Prescription Medicines
R&D
Custom Research
Pharmaceutical Events & Conferences
Contact
Terms & Conditions
Privacy
Home >
The Pharmaceutical Market: France
Management Report
Published: January 2010
Pages: 96
Tables: For full details, please email keithw@cmsinfo.com
From: GBP 595.00 Buy Now!
Research from: Espicom
Sector: Prescription Medicines
Espicom’s in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data for raw materials and finished products and essential industry contacts. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year.
Overall market growth has been comparatively low at around 5.0% per annum and is expected to average 2.7% in local terms in the medium term with government cost-containment programmes exerting downward pressure on reimbursable products. The hospital market has been much more dynamic with growth rates twice this figure in recent years, although growth rates are now falling due to greater regulatory controls in this sector and fewer innovative drugs coming to market.
The underdeveloped generics market is undergoing rapid expansion boosted by government incentives and the loss of patent protection for several high-volume products. The stagnating OTC market has also started to expand as a result of government moves to end reimbursement for a wide range of products assigned a low medical value rating.
France is the third largest producer of pharmaceuticals in the world, accounting for 7% of global pharmaceutical output. Many multinationals have strategic manufacturing sites in France. However, the country is gradually losing out competitively to other European countries with more attractive business environments, such as Ireland, and to low cost producers in Eastern Europe and South America.
The increasingly competitive business environment has resulted in many smaller independent producers being acquired by multinational groups, recent examples being the acquisition of Fournier Pharma by Solvay of Belgium and the acquisition of Negma-Lerads by Wockhardt of India.
France has also lost ground in the field of pharmaceutical research with the majority of multinationals preferring to concentrate their research efforts in their home country or in the US. Oncology research remains one of the few growth areas, due to the launch of a national cancer plan.
Highly detailed report content
MARKET OUTLOOK
Key national data projections
Pharmaceutical Market Analysis
Current market size
Market structure
Unique 5-year market projections
Imports
Domestic manufacturing
Exports
Research & development
Pharmaceutical regulatory analysis
Including regulation, pricing & reimbursement and intellectual property
Pharmaceutical distribution
Healthcare analysis
Including demographics, healthcare system, health expenditure, healthcare infrastructure and personnel
The underdeveloped generics market is undergoing rapid expansion boosted by government incentives and the loss of patent protection for several high-volume products. The stagnating OTC market has also started to expand as a result of government moves to end reimbursement for a wide range of products assigned a low medical value rating.
France is the third largest producer of pharmaceuticals in the world, accounting for 7% of global pharmaceutical output. Many multinationals have strategic manufacturing sites in France. However, the country is gradually losing out competitively to other European countries with more attractive business environments, such as Ireland, and to low cost producers in Eastern Europe and South America.
The increasingly competitive business environment has resulted in many smaller independent producers being acquired by multinational groups, recent examples being the acquisition of Fournier Pharma by Solvay of Belgium and the acquisition of Negma-Lerads by Wockhardt of India.
France has also lost ground in the field of pharmaceutical research with the majority of multinationals preferring to concentrate their research efforts in their home country or in the US. Oncology research remains one of the few growth areas, due to the launch of a national cancer plan.
Highly detailed report content
MARKET OUTLOOK
Key national data projections
Pharmaceutical Market Analysis
Current market size
Market structure
Unique 5-year market projections
Imports
Domestic manufacturing
Exports
Research & development
Pharmaceutical regulatory analysis
Including regulation, pricing & reimbursement and intellectual property
Pharmaceutical distribution
Healthcare analysis
Including demographics, healthcare system, health expenditure, healthcare infrastructure and personnel